Like other fusion-related models of tRCC, SFPQ-TFE3-driven renal tumorigenesis is accompanied by early activation of the mTORC1 pathway, mediated by increased V-ATPase levels. The gene discussed is TFE3; the disease is renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.